Ignite Creation Date:
2024-05-06 @ 1:09 AM
Last Modification Date:
2024-10-26 @ 11:00 AM
Study NCT ID:
NCT01744197
Status:
COMPLETED
Last Update Posted:
2018-10-25
First Post:
2012-12-04
Brief Title:
Synera Venipuncture Pain
Sponsor:
US Oncology Research
Organization:
US Oncology Research
Study Overview
Official Title:
Effect of Synera in Reducing Pain Associated With Venipuncture and Superficial Dermatologic Procedures
Status:
COMPLETED
Status Verified Date:
2018-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Synera which is a heated topical patch containing both lidocaine and tetracaine is intended to reduce the pain associated with venipuncture and superficial dermatologic procedures by numbing the skin This study will test the effectiveness of the Synera lidocainetetracaine patch when administered for 30 5 minutes to provide dermal anesthesia in adult oncology patients undergoing venipuncture as part of their care for treatment or diagnostics laboratory or imaging Compared to the use of the placebo patch this study hypothesizes that the difference of 1 cm on the 0-10 visual analogue scale VAS will be observed 30 minutes after the use of the Synera patch Pain intensity will be assessed by a 0-10 VAS
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None